Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

Publisher Name :
Date: 15-Jun-2013
No. of pages: 123
Inquire Before Buying

There are more than 1400 sustained or controlled release drugs approved all over the world. Revenues within the global generics market reached an estimated value of $265 b in 2012, showing a growth of 9.3% throughout the year. The contribution of generics is approximately 20% of the overall international pharmaceutical market. Utilization of generic in terms of volume is higher in the US and lower in Japan, 89% and 24% respectively.

The oral drug delivery market remains the largest slice of the overall drug delivery market, with more than 52% of market share. It is presently valued at $49 billion and is expected to reach over $90 billion by 2016, at a CAGR of 11%. The growth in the oral drug delivery market shall be driven primarily by newer technologies enabling controlled release formulations of oral drugs and oral formulations of injectable only drugs. Global injectable drug delivery market is expected to be worth $29b by 2015.

Novel drug delivery systems (NDDS) offer many more advantages, which include improved therapy by increasing the efficacy and duration of drug activity, increased patient compliance through decreased dosing frequency and convenient routes of administration, and improved targeting for a specific site to reduce unwanted side effects. The challenge for both drug and drug delivery companies is to deliver both existing and emerging drug technologies in a manner that improves the current benefits enjoyed by the patients.

The generic market with reference to innovative molecule (NCE) has become very competitive as several companies have already filed ANDA's for potential generic drugs in the near term. The study of the novel drug delivery companies and their formulation technologies will provide the potential value added opportunity in the generic field in terms of patient’s compliance or bioavailability enhancement. It will also provide an enhanced life cycle for drugs under patent coverage (life cycle extension).

This comprehensive report on novel drug delivery system focuses mainly on the oral and injectable formulations of pharmaceuticals and specialty companies. This report enumerates the various formulation technologies involved in making value added formulations, pharmaceutical applications and advantages of specific technologies. Wherever possible, marketed drugs using a similar technology have been discussed as proof of validation along with the status of additional pipeline. The discussed proprietary formulation technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

This report will be helpful for those pharma companies who are exploring novel opportunities for their growth by in-licensing formulation technology or value added pipeline drugs available/being studied in the market.

Innovative Drug Delivery Systems: Novel Product and Formulation Technology Licensing Opportunities for Generic Pharmaceutical Companies

Table Of Contents

1. Global Generic Business – Present Status and Future Opportunities
2. Therapeutic focus and Trends in Advanced drug Delivery System based on recent deals
3. Patent expiry impact and generic companies strategies –Super generics
4. The relationship between solubility and permeability in formulations
5. Formulation approach for water –insoluble drugs and oral peptide delivery
6. FDA guidelines for 505 (b)(2) applications and advantage of development
7. Types of changes allowed in 505 (b)(2) development and its advantage
8. Regulatory challenges in clinical data requirement in 505(b)(2) development and safety studies
9. Analysis, Application and Advantages of formulations technologies for more than 75 pharma companies with over 100 formulation technologies in oral and injectable formulations discussed
10. Late stage pipeline development for discussed specialty and major Pharma companies
11. The discussed formulations proprietary technologies includes Colal, Glide SDI, Arestat, GeoClock, GeoMatrix, FlashTab, Lock Tab, Medusa, Eligen, Oradur, EnteriCare and Saber.

  • Healthy Diet Demand In Developed Economies To Boost Nutraceuticals
    As customers scuffle to keep up with the frantic lifestyles, the necessity for healthy nutrition rises owing to dearth of time to spend on laborious exercises.  Customers are shifting their attention to swift and healthy food behaviours. Increase in intake of beverages and functional food has offered makers of nutraceuticals with money-spinning prospects to benefit [...]
  • World Economic Forum Unveils Top 10 Emerging Technologies of 2016
    The World Economic Forum (WEF) and Scientific American lately unveiled the major technological innovation list of the top ten emerging technologies of 2016. This list emphasizes on the technological developments which have the supremacy to transform industries, protect the planet, and improve lives. It also presents an opening to discuss any societal, human, economic or [...]
  • Siemens Adds To the Growth of Wind Power Generation Market
    Siemens has been presenting ground-breaking strategies and pioneering solutions for energy generation for an intelligent power supply globally. With an expansive portfolio and wide-ranging proficiency in wind power generation, Siemens is likely to aid in increasing the share of wind power in the US energy mix. With New Mexico’s vicinity to significant wind energy areas, [...]
  • Global Public Safety LTE Ecosystem Overview
    In view of its flourishing ecosystem, spectrum flexibility and performance metrics, LTE has emerged as the leading candidate for public safety mobile broadband networks. Public safety organizations and establishments have already begun planning to advance their networks to LTE-based public safety solutions. LTE provisions a varied range of services, from high bandwidth data services to [...]
  • RnR Market Research: Biochips Market Insights
    Growing R&D investment and subcontracting of pharmaceutical companies would lead to growth in biochips market in Asia along with an increase in the application of biochips products is estimated to improve opportunity for the global biochip market. Conversely, the high cost involved in manufacturing of biochips can be seen as a challenge for the same. [...]
  • Global Liposomes Drug Delivery Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 4000 Onwards        Pages: 113
    Notes: Sales, means the sales volume of Liposomes Drug Delivery Revenue, means the sales value of Liposomes Drug Delivery This report studies sales (consumption) of Liposomes Drug Delivery in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, focuses on top players in these regions/countries, with sales, price, revenue and market share for each player in these regions, covering - Enzon - Gilead Sciences - ......
  • China Liposomes Drug Delivery Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 3200 Onwards        Pages: 101
    This report studies sales (consumption) of Liposomes Drug Delivery in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Johnson & Johnson - Gilead Sciences - Luye Pharma - Sun Pharmaceutical - Pacira - Fudan-Zhangjiang - Sigma-Tau Group - Teva Pharmaceutical - CSPC - Novartis - Crucell - Celsion Corporation - Kingond Pharm - Shanghai Ne......
  • China Monoclonal Antibodies Drug Delivery Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 3200 Onwards        Pages: 103
    This report studies sales (consumption) of Monoclonal Antibodies Drug Delivery in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Alkermes - Johnson & Johnson - Heron - Janssen Biotech - Eisai - Perrigo - EnColl Corporation - Enzon Pharmaceuticals - Gilead Sciences - Nektar Therapeutics - PDL BioPharma - pSivida Corp - SurModics - Tol......
  • China Polymers Drug Delivery Sales Market Report 2021
    Published: 22-Aug-2016        Price: US 3200 Onwards        Pages: 105
    This report studies sales (consumption) of Polymers Drug Delivery in China market, focuses on the top players, with sales, price, revenue and market share for each player, covering - Alkermes - Johnson & Johnson - Heron - Janssen Biotech - Eisai - Perrigo - EnColl Corporation - Enzon Pharmaceuticals - Gilead Sciences - Nektar Therapeutics - PDL BioPharma - pSivida Corp - SurModics - Tolmar ......
  • Global Monoclonal Antibodies Drug Delivery Market Professional Survey Report 2016
    Published: 19-Aug-2016        Price: US 3500 Onwards        Pages: 110
    Notes: Production, means the output of Monoclonal Antibodies Drug Delivery Revenue, means the sales value of Monoclonal Antibodies Drug Delivery This report studies Monoclonal Antibodies Drug Delivery in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in ......
  • Global Liposomes Drug Delivery Market Research Report 2021
    Published: 12-Aug-2016        Price: US 2900 Onwards        Pages: 109
    Notes: Sales, means the sales volume of Liposomes Drug Delivery Revenue, means the sales value of Liposomes Drug Delivery This report studies Liposomes Drug Delivery in Global market, especially in North America, Europe, China, Japan, India and Southeast Asia, focuses on top manufacturers in global market, with sales, price, revenue and market share for each manufacturer, covering - Enzon - Gilead Sciences - Pacira - Teva Pharmaceutical......
  • Global Liposomes Drug Delivery Market Professional Survey Report 2016
    Published: 05-Aug-2016        Price: US 3500 Onwards        Pages: 114
    Notes: Production, means the output of Liposomes Drug Delivery Revenue, means the sales value of Liposomes Drug Delivery This report studies Liposomes Drug Delivery in Global market, especially in North America, Europe, China, Japan, Southeast Asia and India, with production, revenue, consumption, import and export in these regions, from 2011 to 2015, and forecast to 2021. This report focuses on top manufacturers in global market, with production, pric......
  • United States Liposomes Drug Delivery Sales Market Report 2021
    Published: 05-Aug-2016        Price: US 3800 Onwards        Pages: 102
    This report studies sales (consumption) of Liposomes Drug Delivery in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering Johnson & Johnson Gilead Sciences Luye Pharma Sun Pharmaceutical Pacira Fudan-Zhangjiang Sigma-Tau Group Teva Pharmaceutical CSPC Novartis Crucell Celsion Corporation Kin......
  • United States Monoclonal Antibodies Drug Delivery Sales Market Report 2021
    Published: 05-Aug-2016        Price: US 3800 Onwards        Pages: 104
    This report studies sales (consumption) of Monoclonal Antibodies Drug Delivery in USA market, focuses on the top players, with sales, price, revenue and market share for each player in USA, covering Alkermes Johnson & Johnson Heron Janssen Biotech Eisai Perrigo EnColl Corporation Enzon Pharmaceuticals Gilead Sciences Nektar Therapeutics PDL BioPharma pSivida Corp......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - sales@rnrmarketresearch.com / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs